EarlySight, an EPFL spin-off developing the next generation of eye diseases diagnostic tool has announced the first closing of CHF 2.3 million out of a CHF 3 million seed funding round.

Written by

Investors

Verve Event Zurich Investors

Our sophisticated investors include visionary family offices, leading wealth managers, institutions, founders, and senior executives. These individuals and organizations are all committed to shaping the next generation of innovation.

Learn more

Privacy Preference Center